Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | sodium channel, voltage-gated, type IX, alpha subunit | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | PAK box P21 Rho binding | 0.0101 | 0.0542 | 0.0658 |
Echinococcus multilocularis | serine:threonine protein kinase PAK 4 | 0.0543 | 0.8243 | 1 |
Schistosoma mansoni | protein kinase | 0.0185 | 0.1997 | 1 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0185 | 0.1997 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PAK 4 | 0.0543 | 0.8243 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0185 | 0.1997 | 1 |
Loa Loa (eye worm) | P21-Rho-binding domain-containing protein | 0.0101 | 0.0542 | 0.0485 |
Echinococcus multilocularis | serine:threonine protein kinase PAK 3 | 0.0174 | 0.1818 | 0.1656 |
Trypanosoma brucei | aurora B kinase | 0.0185 | 0.1997 | 0.5 |
Trichomonas vaginalis | STE family protein kinase | 0.0174 | 0.1818 | 0.9072 |
Schistosoma mansoni | protein kinase | 0.0174 | 0.1818 | 0.9072 |
Loa Loa (eye worm) | AUR protein kinase | 0.0185 | 0.1997 | 0.1949 |
Schistosoma mansoni | tyrosine kinase | 0.0101 | 0.0542 | 0.2487 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0185 | 0.1997 | 1 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0185 | 0.1997 | 0.5 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0185 | 0.1997 | 1 |
Entamoeba histolytica | protein kinase , putative | 0.0185 | 0.1997 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0185 | 0.1997 | 0.189 |
Entamoeba histolytica | protein kinase, putative | 0.0185 | 0.1997 | 1 |
Entamoeba histolytica | p21-activated kinase | 0.0174 | 0.1818 | 0.8764 |
Trichomonas vaginalis | AGC family protein kinase | 0.0185 | 0.1997 | 1 |
Echinococcus multilocularis | PAK box P21 Rho binding | 0.0104 | 0.0603 | 0.0079 |
Brugia malayi | WH1 domain containing protein | 0.0101 | 0.0542 | 0.0485 |
Echinococcus multilocularis | p21 activated protein kinase 1 Dpak1 | 0.0174 | 0.1818 | 0.1656 |
Trichomonas vaginalis | AGC family protein kinase | 0.0185 | 0.1997 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0101 | 0.0542 | 0.2487 |
Echinococcus granulosus | serine:threonine protein kinase PAK 3 | 0.0174 | 0.1818 | 0.2205 |
Toxoplasma gondii | aurora kinase | 0.0185 | 0.1997 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.0104 | 0.0603 | 0.0416 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0185 | 0.1997 | 1 |
Trichomonas vaginalis | STE family protein kinase | 0.0174 | 0.1818 | 0.9072 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0185 | 0.1997 | 0.1949 |
Schistosoma mansoni | hypothetical protein | 0.0101 | 0.0542 | 0.2487 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0185 | 0.1997 | 1 |
Giardia lamblia | Aurora kinase | 0.0185 | 0.1997 | 1 |
Echinococcus granulosus | aurora kinase A | 0.0185 | 0.1997 | 0.2423 |
Leishmania major | protein kinase, putative | 0.0185 | 0.1997 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.1757 | 0.1707 |
Brugia malayi | serine/threonine kinase 12 | 0.0185 | 0.1997 | 0.1949 |
Brugia malayi | P21-Rho-binding domain containing protein | 0.0101 | 0.0542 | 0.0485 |
Trichomonas vaginalis | STE family protein kinase | 0.0174 | 0.1818 | 0.9072 |
Loa Loa (eye worm) | AUR protein kinase | 0.0185 | 0.1997 | 0.1949 |
Brugia malayi | Protein kinase domain | 0.0174 | 0.1818 | 0.1768 |
Entamoeba histolytica | protein kinase, putative | 0.0104 | 0.0603 | 0.0416 |
Schistosoma mansoni | protein kinase | 0.0101 | 0.0542 | 0.2487 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0101 | 0.0542 | 0.2487 |
Schistosoma mansoni | protein kinase | 0.0174 | 0.1818 | 0.9072 |
Echinococcus multilocularis | aurora kinase A | 0.0185 | 0.1997 | 0.189 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0185 | 0.1997 | 0.5 |
Brugia malayi | P21-Rho-binding domain containing protein | 0.0101 | 0.0542 | 0.0485 |
Entamoeba histolytica | protein kinase, putative | 0.0185 | 0.1997 | 1 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0185 | 0.1997 | 0.1949 |
Echinococcus granulosus | serine:threonine protein kinase PAK 3 | 0.0174 | 0.1818 | 0.2205 |
Schistosoma mansoni | protein kinase | 0.0104 | 0.0603 | 0.28 |
Trichomonas vaginalis | AGC family protein kinase | 0.0185 | 0.1997 | 1 |
Trichomonas vaginalis | STE family protein kinase | 0.0104 | 0.0603 | 0.28 |
Echinococcus granulosus | neural Wiskott Aldrich syndrome protein | 0.0101 | 0.0542 | 0.0658 |
Entamoeba histolytica | protein kinase, putative | 0.0174 | 0.1818 | 0.8764 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 0.1757 | 0.8759 |
Schistosoma mansoni | wiskott-aldrich syndrome protein | 0.0101 | 0.0542 | 0.2487 |
Echinococcus granulosus | 3'partial|serine:threonine protein kinase PAK 2 | 0.0101 | 0.0542 | 0.0658 |
Echinococcus multilocularis | serine:threonine protein kinase PAK 3 | 0.0174 | 0.1818 | 0.1656 |
Entamoeba histolytica | protein kinase, putative | 0.0104 | 0.0603 | 0.0416 |
Loa Loa (eye worm) | AUR protein kinase | 0.0185 | 0.1997 | 0.1949 |
Trichomonas vaginalis | STE family protein kinase | 0.0174 | 0.1818 | 0.9072 |
Echinococcus granulosus | p21 activated protein kinase 1 Dpak1 | 0.0174 | 0.1818 | 0.2205 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0185 | 0.1997 | 0.2423 |
Schistosoma mansoni | hypothetical protein | 0.0101 | 0.0542 | 0.2487 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0185 | 0.1997 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 6.0458 | Inhibition of NaV1.7 ion channel (unknown origin) | ChEMBL. | 23177785 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.